A Role for Stat1 in the Regulation of Lipopolysaccharide-Induced Interleukin-1 β Expression
Authors:
- 1 October 2006
- journal article
- research article
- Published by SAGE Publications in Journal of Interferon & Cytokine Research
- Vol. 26 (10) , 739-747
Abstract
Because the induction of interleukin-1β (IL-1β) is critical to antibacterial host defenses and its excessive generation is a prominent component of sepsis, regulation of this proinflammatory cytokine is a critical factor in the immune response to lipopolysaccharide (LPS). We previously showed that LPS-induced IL-1β expression was regulated by a Stat1-dependent, nitric oxide (NO)-mediated mechanism. Subsequent in vivo studies showed that whereas Stat1 had a role in the downregulation of IL-1β expression, it had a more significant effect on its initial induction. Although both interferon-β (IFN-β) and IFN-γ activate Stat1, the early appearance of IFN-β in the circulation after LPS administration suggested its pivotal role in Stat1-mediated IL-1β expression in vivo. Further in vitro analysis of peritoneal macrophages from IFN-β–/–, Stat1–/–, and caspase-1–/– mice and their wild-type controls following LPS stimulation demonstrated that IL-1β mRNA was expressed in these mice but not in macrophages from MyD88–/– mice. Despite the presence of IL-1β mRNA, IL-1β protein was markedly reduced in the absence of Stat1 activation in macrophages derived from IFN-β–/– and Stat1–/– mice or in the absence of caspase-1 activity, which itself was dependent on Stat1 activation. These studies support the hypothesis that the expression of IL-1β requires both the MyD88-dependent induction of IL-1β mRNA and pro-IL-1β as well as the MyD88-independent, Stat1-mediated processing of that gene product into active cytokine.Keywords
This publication has 36 references indexed in Scilit:
- Role of Caspase 1 in Murine Antibacterial Host Defenses and Lethal EndotoxemiaInfection and Immunity, 2002
- IFN- γ Inhibits Lipopolysaccharide-Induced Interleukin-1 β in Primary Murine Macrophages via a Stat1-Dependent PathwayJournal of Interferon & Cytokine Research, 2001
- Synergy between Interferon-γ and Tumor Necrosis Factor-α in Transcriptional Activation Is Mediated by Cooperation between Signal Transducer and Activator of Transcription 1 and Nuclear Factor κBJournal of Biological Chemistry, 1997
- Targeted Disruption of the Stat1 Gene in Mice Reveals Unexpected Physiologic Specificity in the JAK–STAT Signaling PathwayCell, 1996
- Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group1994
- Endogenous interferon α/β produced by Kupffer cells inhibits interleukin-1, tumor necrosis factor α production and interleukin-2-induced activation of nonparenchymal liver cellsCancer Immunology, Immunotherapy, 1991
- Interleukin-1 receptor antagonist reduces mortality from endotoxin shockNature, 1990
- Pretreatment with recombinant murine tumor necrosis factor alpha/cachectin and murine interleukin 1 alpha protects mice from lethal bacterial infection.Journal of Experimental Medicine, 1989
- Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets.Journal of Experimental Medicine, 1989
- Production of interferon by in vitro derived bone marrow macrophagesCellular Immunology, 1981